SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,019,000 | -90.4% | 25,850 | -79.2% | 0.06% | -91.5% |
| Q4 2020 | $21,141,000 | +178.8% | 124,000 | +129.6% | 0.77% | +96.7% |
| Q3 2020 | $7,583,000 | -74.2% | 54,000 | -70.6% | 0.39% | -86.2% |
| Q2 2020 | $29,406,000 | +67.6% | 183,400 | +2.2% | 2.83% | +35.7% |
| Q1 2020 | $17,549,000 | +24.8% | 179,400 | +64.6% | 2.08% | +68.5% |
| Q4 2019 | $14,065,000 | +86.7% | 109,000 | +9.0% | 1.24% | -3.9% |
| Q3 2019 | $7,532,000 | +256.1% | 100,000 | +525.0% | 1.29% | +51.8% |
| Q2 2018 | $2,115,000 | -6.7% | 16,000 | -68.0% | 0.85% | +27.7% |
| Q3 2017 | $2,268,000 | +124.3% | 50,000 | +66.7% | 0.66% | +65.6% |
| Q2 2017 | $1,011,000 | -58.8% | 30,000 | -25.0% | 0.40% | -46.2% |
| Q3 2016 | $2,456,000 | +25.8% | 40,000 | -60.0% | 0.75% | -16.0% |
| Q1 2016 | $1,952,000 | +838.5% | 100,000 | +1751.9% | 0.89% | +909.1% |
| Q4 2015 | $208,000 | +20.2% | 5,400 | 0.0% | 0.09% | -11.1% |
| Q3 2015 | $173,000 | +5.5% | 5,400 | 0.0% | 0.10% | +17.9% |
| Q2 2015 | $164,000 | +127.8% | 5,400 | 0.0% | 0.08% | +127.0% |
| Q1 2015 | $72,000 | – | 5,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |